CIBC Innovation Banking Provides Growth Capital to InsightRX
"We are proud that InsightRX is leading the transition from the traditional 'one-size-fits-all' approach in drug dosing to a more individualized treatment paradigm that considers the unique characteristics of patient subgroups and the specific needs of each patient. This shift is not just pivotal for patient care but also for the introduction of new drugs to the market. To help us achieve our strategic vision of transforming patient care, we worked with CIBC for the necessary financing to accelerate our growth. CIBC showed intellectual curiosity about the intricacies of our business and were thoughtful in their approach,” said Sirj Goswami, Ph.D., CEO and co-founder of InsightRX.
“We’re excited to work with the InsightRX leadership team as they use artificial intelligence to blaze a trail in drug development in biopharma clinical trials and in helping healthcare providers ensure patients are receiving optimal drug dosing,” said
About CIBC Innovation Banking
CIBC Innovation Banking delivers strategic advice, cash management and funding to innovation companies across
About InsightRX
InsightRX is a healthcare technology company that provides a cloud-based clinical decision support platform that applies quantitative pharmacology and artificial intelligence (AI) to enhance therapeutic decision-making from phase I drug development through to individualized patient treatment at the point of care. The company's platform provides an individualized understanding of a patient's response to treatment, enabling medical professionals to bring new drugs to market efficiently, improve treatment effectiveness, and provide direct benefits to patients. Learn more at InsightRX.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240223903604/en/
Media
Source: CIBC Innovation Banking